Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26795

1.

Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency Syndrome.

Toboni MD, Bevis KS.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002905. [Epub ahead of print]

PMID:
30303925
2.

Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy.

Huntley JH, Richter LA, Blackford AL, Aliu O, Pollack CE.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002914. [Epub ahead of print]

PMID:
30303924
3.

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002933. [Epub ahead of print]

PMID:
30303923
4.

Complication Rates and Outcomes After Hysterectomy in Transgender Men.

Bretschneider CE, Sheyn D, Pollard R, Ferrando CA.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002936. [Epub ahead of print]

PMID:
30303922
5.

Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy.

Ruiz MP, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002912. [Epub ahead of print]

PMID:
30303921
6.

Implementation of the "Pregnancy Reasonably Excluded Guide" for Pregnancy Assessment: A Quality Initiative in Outpatient Gynecologic Surgery.

Wyatt MA, Ainsworth AJ, DeJong SR, Cope AG, Long ME.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002917. [Epub ahead of print]

PMID:
30303920
7.

Novel Approach to Reduction of an Incarcerated Uterus.

Gardner B, Kozakiewicz ML, Whitecar PW, Nitsche JF, Brost BC.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002934. [Epub ahead of print]

PMID:
30303919
8.

Starting Health Disparities Education During Resident Orientation: Our Patients, Our Community.

Talati AN, Lappen JR, Bondurant-Sullivan A, Cossler NJ, Wieczorek M, Gecsi KS.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002911. [Epub ahead of print]

PMID:
30303918
9.

The Sign of Leser-Trelát and Malignant Acanthosis Nigricans Associated With Fallopian Tube Carcinoma.

West L, Carlson M, Wallis L, Goff HW.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002920. [Epub ahead of print]

PMID:
30303917
10.

Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

van Nagell JR Jr, Burgess BT, Miller RW, Baldwin L, DeSimone CP, Ueland FR, Huang B, Chen Q, Kryscio RJ, Pavlik EJ.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002921. [Epub ahead of print]

PMID:
30303916
11.

Ultrasound Screening for Ovarian Cancer: Are We There Yet?

Robertson SE, Peipert JF.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002962. [Epub ahead of print] No abstract available.

PMID:
30303915
12.

Connect the Dots-November 2018.

Sinning K, Eke AC, Spellman C, Chescheir NC.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002957. [Epub ahead of print] No abstract available.

PMID:
30303914
13.

What Is New in Bladder Pain?: Best Articles From the Past Year.

Whiteside JL.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002951. [Epub ahead of print]

PMID:
30303913
14.

Racial and Ethnic Disparities in the Incidence of Severe Maternal Morbidity in the United States, 2012-2015.

Admon LK, Winkelman TNA, Zivin K, Terplan M, Mhyre JM, Dalton VK.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002937. [Epub ahead of print]

PMID:
30303912
15.

Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center.

Grechukhina O, Deshmukh U, Fan L, Kohari K, Abdel-Razeq S, Bahtiyar MO, Sfakianaki AK.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002940. [Epub ahead of print]

PMID:
30303911
16.

Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System.

Suh-Burgmann E, Flanagan T, Osinski T, Alavi M, Herrinton L.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002939. [Epub ahead of print]

PMID:
30303910
17.

A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.

Sonalkar S, Hunter T, Gurney EP, McAllister A, Schreiber CA.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002926. [Epub ahead of print]

PMID:
30303909
18.

External Use of an Oxidized Regenerated Cellulose Agent in the Treatment of Labial Agglutination in Postmenopausal Women.

Wyman AM, Lafranchise E, Lynch C.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002919. [Epub ahead of print]

PMID:
30303908
19.

Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting.

DeFrancesco MS, Waldman RN, Pearlstone MM, Karanik D, Bernhisel R, Logan J, Alico L, Adkins RT.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002916. [Epub ahead of print]

PMID:
30303907
20.

Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With Uterine Serous Carcinoma.

Gressel GM, Turker L, Dioun SM, McGinn AP, Nevadunsky NS.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002932. [Epub ahead of print]

PMID:
30303906

Supplemental Content

Loading ...
Support Center